Monterey Bio Acquisition Corporation

MTRY · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$1-$1-$0
Dep. & Amort.$0$0$0
Deferred Tax$0$0$0
Stock-Based Comp.$0$0$0
Change in WC$1-$0$0
Other Non-Cash-$1$0$0
Operating Cash Flow-$1-$1$0
Investing Activities
PP&E Inv.$0$0$0
Net Acquisitions$0$0$0
Inv. Purchases$0$0$0
Inv. Sales/Matur.$0$0$0
Other Inv. Act.$96-$116$0
Investing Cash Flow$96-$116$0
Financing Activities
Debt Repay.$0$0$0
Stock Issued$0$113$0
Stock Repurch.-$96$0$0
Dividends Paid$0$0$0
Other Fin. Act.-$95$118$0
Financing Cash Flow-$95$118$0
Forex Effect$0$0$0
Net Chg. in Cash-$0$0$0
Supplemental Information
Beg. Cash$1$0$0
End Cash$0$1$0
Free Cash Flow-$1-$1$0
Monterey Bio Acquisition Corporation (MTRY) Financial Statements & Key Stats | AlphaPilot